Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Tripos and Sepracor to collaborate on discovery of HIV protease inhibitors

Feb. 26, 1998

Alferon N Injection for HIV-infected patients makes progress

Feb. 26, 1998

Nucleoside with potent and selective anti-HIV and anti-HBV activity

Feb. 25, 1998

Quinolone HIV integrase inhibitors prepared at Warner-Lambert

Feb. 24, 1998

Controlled trial of peptide T for cognitive impairment in HIV-infected patients

Feb. 23, 1998

Nucleoside analogues from BioChem Therapeutic show potential for HIV/AIDS

Feb. 23, 1998

U.S. patent will issue covering Theratechnologies' AIDS gene therapy

Feb. 20, 1998

Transgenic production program begins for novel HIV therapeutic

Feb. 19, 1998

Novel imidazoles from Shionogi target lymph nodes

Feb. 19, 1998

Sea cucumber-based agent may increase well-being in HIV/AIDS patients

Feb. 19, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...